Cargando…

Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer

Recent studies have provided evidence of interactions among the gut microbiota (GM), local host immune cells, and intestinal tissues in colon carcinogenesis. However, little is known regarding the functions exerted by the GM in colon cancer (CC), particularly with respect to tumor clinical classific...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanca, Alessandro, Abbondio, Marcello, Fiorito, Giovanni, Pira, Giovanna, Sau, Rosangela, Manca, Alessandra, Muroni, Maria Rosaria, Porcu, Alberto, Scanu, Antonio Mario, Cossu-Rocca, Paolo, De Miglio, Maria Rosaria, Uzzau, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048685/
https://www.ncbi.nlm.nih.gov/pubmed/35495697
http://dx.doi.org/10.3389/fmicb.2022.869523
_version_ 1784695984983375872
author Tanca, Alessandro
Abbondio, Marcello
Fiorito, Giovanni
Pira, Giovanna
Sau, Rosangela
Manca, Alessandra
Muroni, Maria Rosaria
Porcu, Alberto
Scanu, Antonio Mario
Cossu-Rocca, Paolo
De Miglio, Maria Rosaria
Uzzau, Sergio
author_facet Tanca, Alessandro
Abbondio, Marcello
Fiorito, Giovanni
Pira, Giovanna
Sau, Rosangela
Manca, Alessandra
Muroni, Maria Rosaria
Porcu, Alberto
Scanu, Antonio Mario
Cossu-Rocca, Paolo
De Miglio, Maria Rosaria
Uzzau, Sergio
author_sort Tanca, Alessandro
collection PubMed
description Recent studies have provided evidence of interactions among the gut microbiota (GM), local host immune cells, and intestinal tissues in colon carcinogenesis. However, little is known regarding the functions exerted by the GM in colon cancer (CC), particularly with respect to tumor clinical classification and lymphocyte infiltration. In addition, stool, usually employed as a proxy of the GM, cannot fully represent the original complexity of CC microenvironment. Here, we present a pilot study aimed at characterizing the metaproteome of CC-associated colonic luminal contents and identifying its possible associations with CC clinicopathological features. Colonic luminal contents were collected from 24 CC tissue specimens immediately after surgery. Samples were analyzed by shotgun metaproteomics. Almost 30,000 microbial peptides were quantified in the samples, enabling the achievement of the taxonomic and functional profile of the tumor-associated colonic luminal metaproteome. Upon sample aggregation based on tumor stage, grade, or tumor-infiltrating lymphocytes (TILs), peptide sets enabling discrimination of sample groups were identified through discriminant analysis (DA). As a result, Bifidobacterium and Bacteroides fragilis were significantly enriched in high-stage and high-grade CC, respectively. Among metabolic functions, formate–tetrahydrofolate ligase was significantly associated with high-stage CC. Finally, based on the results of this pilot study, we assessed the optimal sample size for differential metaproteomic studies analyzing colonic luminal contents. In conclusion, we provide a detailed picture of the microbial and host components of the colonic luminal proteome and propose promising associations between GM taxonomic/functional features and CC clinicopathological features. Future studies will be needed to verify the prognostic value of these data and to fully exploit the potential of metaproteomics in enhancing our knowledge concerning CC progression.
format Online
Article
Text
id pubmed-9048685
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90486852022-04-29 Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer Tanca, Alessandro Abbondio, Marcello Fiorito, Giovanni Pira, Giovanna Sau, Rosangela Manca, Alessandra Muroni, Maria Rosaria Porcu, Alberto Scanu, Antonio Mario Cossu-Rocca, Paolo De Miglio, Maria Rosaria Uzzau, Sergio Front Microbiol Microbiology Recent studies have provided evidence of interactions among the gut microbiota (GM), local host immune cells, and intestinal tissues in colon carcinogenesis. However, little is known regarding the functions exerted by the GM in colon cancer (CC), particularly with respect to tumor clinical classification and lymphocyte infiltration. In addition, stool, usually employed as a proxy of the GM, cannot fully represent the original complexity of CC microenvironment. Here, we present a pilot study aimed at characterizing the metaproteome of CC-associated colonic luminal contents and identifying its possible associations with CC clinicopathological features. Colonic luminal contents were collected from 24 CC tissue specimens immediately after surgery. Samples were analyzed by shotgun metaproteomics. Almost 30,000 microbial peptides were quantified in the samples, enabling the achievement of the taxonomic and functional profile of the tumor-associated colonic luminal metaproteome. Upon sample aggregation based on tumor stage, grade, or tumor-infiltrating lymphocytes (TILs), peptide sets enabling discrimination of sample groups were identified through discriminant analysis (DA). As a result, Bifidobacterium and Bacteroides fragilis were significantly enriched in high-stage and high-grade CC, respectively. Among metabolic functions, formate–tetrahydrofolate ligase was significantly associated with high-stage CC. Finally, based on the results of this pilot study, we assessed the optimal sample size for differential metaproteomic studies analyzing colonic luminal contents. In conclusion, we provide a detailed picture of the microbial and host components of the colonic luminal proteome and propose promising associations between GM taxonomic/functional features and CC clinicopathological features. Future studies will be needed to verify the prognostic value of these data and to fully exploit the potential of metaproteomics in enhancing our knowledge concerning CC progression. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9048685/ /pubmed/35495697 http://dx.doi.org/10.3389/fmicb.2022.869523 Text en Copyright © 2022 Tanca, Abbondio, Fiorito, Pira, Sau, Manca, Muroni, Porcu, Scanu, Cossu-Rocca, De Miglio and Uzzau. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Tanca, Alessandro
Abbondio, Marcello
Fiorito, Giovanni
Pira, Giovanna
Sau, Rosangela
Manca, Alessandra
Muroni, Maria Rosaria
Porcu, Alberto
Scanu, Antonio Mario
Cossu-Rocca, Paolo
De Miglio, Maria Rosaria
Uzzau, Sergio
Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer
title Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer
title_full Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer
title_fullStr Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer
title_full_unstemmed Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer
title_short Metaproteomic Profile of the Colonic Luminal Microbiota From Patients With Colon Cancer
title_sort metaproteomic profile of the colonic luminal microbiota from patients with colon cancer
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048685/
https://www.ncbi.nlm.nih.gov/pubmed/35495697
http://dx.doi.org/10.3389/fmicb.2022.869523
work_keys_str_mv AT tancaalessandro metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT abbondiomarcello metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT fioritogiovanni metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT piragiovanna metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT saurosangela metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT mancaalessandra metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT muronimariarosaria metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT porcualberto metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT scanuantoniomario metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT cossuroccapaolo metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT demigliomariarosaria metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer
AT uzzausergio metaproteomicprofileofthecolonicluminalmicrobiotafrompatientswithcoloncancer